All Articles

With a pivotal drug approval on the horizon, Spruce Biosciences' appointment of a rare disease veteran signals a critical transition from R&D to commercial reality.

With new CEO Eric Augustyn, an active investor from its own ranks, BiggerPockets plans a major platform overhaul to fortify its market dominance.

As DTC darling OGEE enters Sephora, its rigorous organic certification raises the bar for 'clean beauty' and signals a major shift for conscious consumers.

Genius Group's massive share repurchase program aims to boost shareholder value, but a look at its financials reveals a high-stakes gamble. Is this a confident bet or a red flag?

Prolium Bioscience advances its T-cell engager, PRO-203, in trials for scleroderma and lupus, heralding a new, potent strategy against severe autoimmunity.

Hubstaff's 'Time Tracking Solution of the Year' award highlights a pivotal industry shift from simple monitoring to a trust-based model of remote management.

With compelling Phase 2b survival data, NeuroSense is advancing its multi-target ALS drug to a pivotal Phase 3 trial. A deep dive into the science and strategy.

Refinity's new license to turn plastic waste into jet fuel is more than a green initiative; it's a calculated move to rewire petrochemical supply chains.

A cult-favorite US hot chicken brand is landing in the UK via PizzaExpress. We analyze the high-stakes deal, the PE backing, and if Britain is ready for the heat.

AI is forcing a total rebuild of retail marketing. A new report finds leaders are hiring, but a huge skills gap could derail the entire transformation.

Australian radiopharma innovator AdvanCell is planting its flag in Greater Boston with a new HQ and factory, a strategic move to scale its potent Lead-212 therapy.

With 1 in 4 seniors facing isolation, Element Care is using a $100K grant to prove that belonging is a clinical imperative, not just a 'nice-to-have'.

Veea Inc. bolsters its leadership to capture the booming edge AI market, but can seasoned executives overcome daunting financial hurdles and fierce competition?

Fish & Richardson's new AI tool isn't just about efficiency. It's a look at how secure, in-house AI is reshaping the very foundation of patent law.

A renewed six-year contract for 300,000 state employees highlights Empower's market dominance and the critical role of supplemental retirement plans.

As work moves to the browser, so do the threats. Cybersecurity firm MirrorTab hires Colin Britton to scale its 'isolation' tech for a new reality.

From my desk in The Engine Room, I analyze the blueprint behind Thirsty Buddha's bold leap from Canada into Costco UK and LA. This is more than a drink launch.

Provincial ministers met to refocus their collective strategy, confronting the dual challenges of AI integration and unilateral federal policies on international students.

Wynn bets big on a multi-year deal with Netflix's Chef's Table. Is this the new gold standard for luxury hospitality or just an ultra-expensive menu?

A new product launch isn't just about a product. It's a strategic move to expose a 'quality crisis' and force transparency in the booming mushroom market.